ProfileGDS4177 / 1554029_a_at
TitleImatinib treatment of chronic myeloid leukemia cell lines: KU-812, KCL-22 and JURL-MK1
OrganismHomo sapiens


KU-812 KCL-22 JURL-MK1 Imatinib untreated Imatinib untreated Imatinib untreated GSM603100 GSM603099 GSM603098 GSM603097 GSM603102 GSM603101 79% 75% 74% 75% 71% 69% sort by cell line sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM603100KU-812 Imatinib-treated185.579
GSM603099KU-812 non-treated141.3775
GSM603098KCL-22 Imatinib-treated144.8874
GSM603097KCL-22 non-treated152.1675
GSM603102JURL-MK1 Imatinib-treated105.3671
GSM603101JURL-MK1 non-treated88.6969